You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR SYMADINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SYMADINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02025439 ↗ Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness Completed Edward Hines Jr. VA Hospital N/A 2014-02-01 The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery.
NCT04273737 ↗ Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy Recruiting Columbia University Phase 4 2020-02-28 Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SYMADINE

Condition Name

Condition Name for SYMADINE
Intervention Trials
Cerebral Palsy 1
Traumatic Brain Injury 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SYMADINE
Intervention Trials
Brain Injuries, Traumatic 1
Brain Injuries 1
Paralysis 1
Cerebral Palsy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SYMADINE

Trials by Country

Trials by Country for SYMADINE
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SYMADINE
Location Trials
New York 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SYMADINE

Clinical Trial Phase

Clinical Trial Phase for SYMADINE
Clinical Trial Phase Trials
Phase 4 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SYMADINE
Clinical Trial Phase Trials
Completed 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SYMADINE

Sponsor Name

Sponsor Name for SYMADINE
Sponsor Trials
Edward Hines Jr. VA Hospital 1
Columbia University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SYMADINE
Sponsor Trials
U.S. Fed 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.